AU Patent

AU2024204465B2 — Oral peptide drug structure and manufacturing method thereof

Assigned to Merdury Biopharmaceutical Corp · Expires 2026-04-23 · 0y expired

What this patent protects

1 The invention is an oral peptide drug structure mainly comprising: a tablet body and a coating layer covering an outer layer of the tablet body, the tablet body is made of a first excipient mixing with a first penetration accelerator, and the coating layer is made of a second p…

USPTO Abstract

1 The invention is an oral peptide drug structure mainly comprising: a tablet body and a coating layer covering an outer layer of the tablet body, the tablet body is made of a first excipient mixing with a first penetration accelerator, and the coating layer is made of a second penetration accelerator mixing with a peptide. Through the tablet body design of coating the excipient with the peptide, the oral peptide can be stably absorbed.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024204465B2
Jurisdiction
AU
Classification
—
Expires
2026-04-23
Drug substance claim
No
Drug product claim
No
Assignee
Merdury Biopharmaceutical Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.